Titre:
  • Trastuzumab in HER2-negative early breast cancer as adjuvant treatment for circulating tumor cells (CTCs) (Treat CTC).
Auteur:Ignatiadis, Michail; Messina, Carlo; Litière, Saskia; Mavroudis, Dimitris; Dittrich, C; Kong, A; Janni, Wolfgang; Sotiriou, Christos; Piccart-Gebhart, Martine; Pierga, Jean-Yves; Rack, B
Informations sur la publication:SABCS 2014 Resources, San Antonio Breast Cancer Symposium 2014(37: 9-13/12/2014: San Antonio, Tx, USA)
Statut de publication:Publié, 2014-12
Sujet CREF:Cancérologie
Médecine pathologie humaine
Sciences bio-médicales et agricoles
Note générale:Abstract [OT1-2-02] - Session Ongoing Clinical Trials: Ongoing Clinical Trials 1: Circulating Tumor Cells - oral presentation - 10/12/2014
Langue:Anglais